Skip to main content

Regulation of Insulin Secretion and Islet Cell Function

  • Chapter
  • First Online:
Atlas of Diabetes

Abstract

The β cells of the islets of Langerhans are the only cells in the body that produce a ­meaningful quantity of insulin, a hormone that has evolved to be essential for life, exerting critical control over carbohydrate, fat, and protein metabolism. Islets are scattered throughout the pancreas; although they vary in size, they typically contain about 1,000 cells, of which approximately 70% are β cells. A human pancreas contains about one million islets, which comprise only about 2% of the mass of the pancreas. Insulin is released into the portal vein, which means the liver is exposed to particularly high concentrations of insulin.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Habener JF, Kemp DM, Thomas MK: Minireview: transcriptional regulation in pancreatic development. Endocrinology 2005, 146:1025–1034.

    Article  PubMed  CAS  Google Scholar 

  2. Olbrot M, Rud J, Moss LG, Sharma A: Identification of beta-cell-specific insulin gene transcription factor RIPE3b1 as mammalian MafA. Proc Natl Acad Sci U S A 2002, 99:6737–6742.

    Article  PubMed  CAS  Google Scholar 

  3. Kawaguchi Y, Cooper B, Gannon M, et al.: The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors. Nat Genet 2002, 32:128–134.

    Article  PubMed  CAS  Google Scholar 

  4. Edlund H: Transcribing pancreas. Diabetes 1998, 47:1817–1823.

    Article  PubMed  CAS  Google Scholar 

  5. Bonner-Weir S, Orci L: New perspectives on the microvasculature of the islets of Langerhans in the rat. Diabetes 1982, 31:883–939.

    Article  PubMed  CAS  Google Scholar 

  6. Weir GC, Bonner-Weir S: Islets of Langerhans: the puzzle of intraislet interactions and their relevance to diabetes. J Clin Invest 1990, 85:983–987.

    Article  PubMed  CAS  Google Scholar 

  7. Bonner-Weir S, O’Brien TD: Islets in type 2 diabetes: in honor of Dr. Robert C. Turner. Diabetes 2008, 57:2899–2904.

    CAS  Google Scholar 

  8. Orci L: The insulin factory: a tour of the plant surroundings and a visit to the assembly line. Diabetologia 1985, 28:528–546.

    Article  PubMed  CAS  Google Scholar 

  9. Guest PC, Bailyes EM, Rutherford NG, Hutton JC: Insulin secretory granule biogenesis. Biochem J 1991, 274:73–78.

    PubMed  CAS  Google Scholar 

  10. Inada A, Nienaber C, Katsuta H, et al.: Carbonic anhydrase II-positive pancreatic cells are progenitors for both endocrine and exocrine pancreas after birth. Proc Natl Acad Sci U S A 2008, 105:19915–19919.

    Article  PubMed  CAS  Google Scholar 

  11. Bonner-Weir S, Weir GC: New sources of pancreatic beta-cells. Nat Biotechnol 2005, 23:857–861.

    Article  PubMed  CAS  Google Scholar 

  12. Rankin MM, Kushner JA: Adaptive beta-cell proliferation is severely restricted with advanced age. Diabetes 2009, 58:1365–1372.

    Article  PubMed  CAS  Google Scholar 

  13. Finegood DT, Scaglia L, Bonner-Weir S: (Perspective) Dynamics of B-cell mass in the growing rat pancreas: estimation with a simple mathematical model. Diabetes 1995, 44:249–256

    Article  PubMed  CAS  Google Scholar 

  14. Sander M, German MS: The B cell transcription factors and development of the pancreas. J Mol Med 1997, 75:327–340.

    Article  PubMed  CAS  Google Scholar 

  15. Rhodes CJ, Alarcon C: What beta cell defect could lead to hyperproinsulinemia in NIDDM? Diabetes 1994, 43:511–517.

    Article  PubMed  CAS  Google Scholar 

  16. Rhodes CJ: Processing of the insulin molecule. In Diabetes Mellitus: A Fundamental and Clinical Text, edn 3. Edited by LeRoith D, Taylor SI, Olefsky JM. Philadelphia: Lippincott Williams & Wilkins; 2004:27–50.

    Google Scholar 

  17. Easom RA: CaM kinase II: a protein kinase with extraordinary talents germane to insulin exocytosis. Diabetes 1999, 48: 675–684.

    Article  PubMed  CAS  Google Scholar 

  18. Leahy JL, Cooper HE, Deal DA, Weir GC: Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions. J Clin Invest 1986, 77:908–915.

    Google Scholar 

  19. DeVos A, Heimberg H, Quartier E, et al.: Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression. J Clin Invest 1995, 96:2489–2495.

    Article  CAS  Google Scholar 

  20. Matschinsky FM: A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes 1996, 45:223–241.

    Article  PubMed  CAS  Google Scholar 

  21. Eto K, Tsubamoto Y, Terauchi Y, et al.: Role of NADH shuttle system in glucose-induced activation of mitochondrial metabolism and insulin secretion. Science 1999, 283: 981–985.

    Article  PubMed  CAS  Google Scholar 

  22. Henquin JC: Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 2000, 49:1751–1760.

    Article  PubMed  CAS  Google Scholar 

  23. Lovshin JA, Drucker DJ: Incretin-based therapies for type 2 diabetes mellitus. Nat Rev Endocrinol 2009, 5:262–269.

    Article  PubMed  CAS  Google Scholar 

  24. Mears D, Atwater I: Electrophysiology of the pancreatic b-cell. In Diabetes Mellitus: A Fundamental and Clinical Text, edn 2. Edited by LeRoith D, Taylor SI, Olefsky JM. Philadelphia: Lippincott Williams & Wilkins; 2000:47–60.

    Google Scholar 

  25. Gilon P, Shepherd RM, Henquin JC: Oscillations of secretion driven by oscillations of cytoplasmic Ca2 as evidenced in single pancreatic islets. J Biol Chem 1993, 268: 22265–22268.

    PubMed  CAS  Google Scholar 

  26. Porksen N, Munn S, Steers J, et al.: Effects of glucose ingestion versus infusion on pulsatile insulin secretion. Diabetes 1996, 45:1317–1323.

    Article  PubMed  CAS  Google Scholar 

  27. McGarry JD, Dobbins RL: Fatty acids, lipotoxicity and insulin secretion. Diabetolgia 1999, 42:128–138.

    Article  CAS  Google Scholar 

  28. Prentki M, Corkey BE: Are the beta-cell signaling molecules malonyl-CoA and cystolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM? Diabetes 1996, 45:273–283.

    Article  PubMed  CAS  Google Scholar 

  29. Holz GG, Chepurny OG, Schwede F: Epac-selective cAMP analogs: new tools with which to evaluate the signal transduction properties of cAMP-regulated guanine nucleotide exchange factors. Cell Signal 2008, 20:10–20.

    Article  PubMed  CAS  Google Scholar 

  30. Brunzell JD, Robertson RP, Lerner RL, et al.: Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab 1976, 42:222–229.

    Article  PubMed  CAS  Google Scholar 

  31. Ward WK, Bolgiano DC, McKnight B, et al.: Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Invest 1984, 74:1318–1328.

    Article  PubMed  CAS  Google Scholar 

  32. Mitrakou A, Kelley D, Mokan M, et al.: Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 1992, 326:22–29.

    Article  PubMed  CAS  Google Scholar 

  33. Hull RL, Westermark GT, Westermark P, Kahn SE: Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. J Clin Endocrinol Metab 2004, 89:3629–3643.

    Article  PubMed  CAS  Google Scholar 

  34. Murphy R, Ellard S, Hattersley AT: Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes. Nat Clin Pract Endocrinol Metab 2008, 4: 200–213.

    Article  PubMed  CAS  Google Scholar 

  35. Matschinsky FM: Assessing the potential of glucokinase activators in diabetes therapy. Nat Rev Drug Discov 2009, 8:399–416.

    Article  PubMed  CAS  Google Scholar 

  36. Florez JC: Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes? Diabetologia 2008, 51:1100–1110.

    Article  PubMed  CAS  Google Scholar 

  37. Jonas JC, Sharma A, Hasenkamp W, et al.: Chronic hyperglycemia triggers loss of pancreatic beta cell differentiation in an animal model of diabetes. J Biol Chem 1999, 274:14112–14121.

    Article  PubMed  CAS  Google Scholar 

  38. Weir GC, Laybutt DR, Kaneto H, et al.: Beta-cell adaptation and decompensation during the progression of diabetes. Diabetes 2001, 50(Suppl 1):S154–S159.

    Article  PubMed  CAS  Google Scholar 

  39. Weir GC, Bonner-Weir S: Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes 2004, 53(Suppl 3):S16–S21.

    Article  PubMed  CAS  Google Scholar 

  40. Tabak AG, Jokela M, Akbaraly TN, et al.: Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 2009, 373:2215–2221.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gordon C. Weir MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Weir, G.C., Bonner-Weir, S., Sharma, A. (2012). Regulation of Insulin Secretion and Islet Cell Function. In: Skyler, J. (eds) Atlas of Diabetes. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-1028-7_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-1028-7_1

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4614-1027-0

  • Online ISBN: 978-1-4614-1028-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics